Umberto Vitolo

28PUBLICATIONS
167CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyParticle physicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Aug 12, 2026
Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial.

|Aug 05, 2026
First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma.

|Jun 25, 2026
Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma.

|Apr 06, 2026
Loncastuximab Tesirine in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Evidence and Practical Guidance From Italian Clinical Experience.

Francesca Bonello, Andrea Aroldi, Alessia Castellino

|Nov 27, 2025
Better together: epcoritamab boosts R2 in FL.

Umberto Vitolo, Francesca Bonello

|Jun 11, 2025
Copanlisib in combination with rituximab and bendamustine for transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma patients: Results from the phase II multicentre FIL Copa-BR trial from Fondazione Italiana Linfomi (FIL).

Mattia Novo, Pio Manlio Mirko Frascione, Alessia Castellino

Pageof 5

Frequent Collaborators

4 joint publications

Marek Trněný

3 joint publications

Gianluca Gaidano

3 joint publications

Federica Cavallo

3 joint publications

Maurizio Martelli